Clinical Trials Logo
  1. Home
  2. Skin Toxicity
  3. NCT05109858

Skin Toxicity by Oncological Therapies — SKINTOX  

Skin Toxicity Clinical Trial

Official title:
Observational Study on Skin Toxicity by Oncological Therapies

Clinical Trial Summary

This is a multicenter, retrospective and prospective observational study. The project involves the collection of clinical data of patients treated with oncological therapies, to evaluate skin toxicities related to oncological treatment.

Clinical Trial Description

This is a multicenter, retrospective and prospective observational study. The research will include 300 patients treated with clinical practice oncological treatments (approved by Italian Competent Authority, AIFA) from January 2012 to February 2024. Patients will follow the prescribed therapeutic indications according to regular clinical practice and data from their medical records will be collected in a study database. Primary objective of the study is the evaluation of the type, frequency and severity of skin toxicities related to oncological treatment. Secondary objectives are: - Evaluation of the association between skin toxicities due to oncological treatment and drug activity and effectiveness parameters(ORR, PFS, OS); - Evaluation of the association between clinical-pathological features of primary cancer and skin toxicities of oncological treatment; - Evaluation of the optimal management of skin toxicities related to cancer treatment. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05109858
Study type Observational
Source Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori
Contact Matelda Medri
Phone +390543739100
Email matelda.medri@irst.emr.it
Status Recruiting
Phase
Start date March 21, 2019
Completion date February 28, 2025
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT04929834 - Novel Skin Care for Immunotherapy- Related Dermatologic Toxicities N/A
Completed NCT04929847 - Novel Skin Care for Chemotherapy- Related Dermatologic Toxicities N/A
Not yet recruiting NCT03606954 - Potency of Topical Corticosteroids in Combination Preparations Phase 4
Completed NCT01976481 - Serum 25-OH Vitamin D Modulation by Sunbed Use According to EU Guideline EN 60335-2-27 N/A
Completed NCT03448731 - Skin Toxicity in Patients With Metastatic Colorectal Cancer Treated With Anti-EGFR and Chemotherapy (DERMIA) Phase 2
Completed NCT00871429 - Skin Care for Cancer Patients: A Product Satisfaction Survey N/A
Recruiting NCT04469075 - Clindamycin and Triamcinolone in People With Glioblastoma to Prevent Skin-Related Side Effects of Tumor Treating Fields Phase 2
Recruiting NCT04650256 - Application of Chinese Herbal Complementary and Alternative Medicine (CAM) to Improve Human Health and to Further Botanical and Horticultural Sciences N/A
Terminated NCT01317433 - Pre-emptive Cycline Treatment on Cetuximab Induced Skin Toxicity in Colorectal Cancer N/A
Active, not recruiting NCT03167268 - Panitumumab Skin Toxicity Prevention Trial Phase 2
Recruiting NCT06118047 - Crisaborole Ointment for Skin Toxicity Induced by Cetuximab Phase 2